Allergan's Big Deal: A Buyout, Not A Split, Appeases Wary Investors

 
• By Mandy Jackson
  
merger and acquisition business concepts, join company on puzzle pieces, 3d rendering
A merger was the answer to Allergan's woes, not a split. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business